bioRxivCell BiologyPreprint
Cellular senescence dysregulates antiviral interferon responses in idiopathic pulmonary fibrosis
Jun‐Wei B. HughesiD, Yasmina ReisseriD, Franziska HornungiD, Tyler A. U. HilsabeckiD, Fiona SenchynaiD, A L Coelho, Tsung Che Ho, Kevin SchneideriD, David FurmaniD, Cory M. HogaboamiD, Claude Jourdan Le SauxiD, Pierre-Yves Desprez, Stefanie Deinhardt‐EmmeriD
Abstract
Patients with idiopathic pulmonary fibrosis (IPF) are highly vulnerable to respiratory virus infections, but the cellular mechanisms linking fibrotic remodeling to impaired local antiviral defense remain unclear. Here, we investigated how cellular senescence shapes the response of patient-derived healthy and IPF primary lung fibroblasts to influenza A virus (IAV) infection. Transcriptomic profiling identified infection as the driver of gene expression in both DNA damage-induced senescent healthy and IPF fibroblasts and revealed induction of canonical antiviral pathways in both cell states. However, senescent IPF fibroblasts adopted a distinct antiviral response state characterized by a broader set of uniquely induced genes and differential coordination of antiviral transcriptional networks. Functionally, senescence increased viral titers in healthy and IPF fibroblasts, while senescent IPF fibroblasts displayed an altered inflammatory response. Network analysis linked viral response- and cell cycle-associated modules specifically to the senescent healthy infected state, whereas these programs were weaker in senescent IPF fibroblasts. Transcription factor inference identified IRF3 and STAT1 as candidate regulators of this altered antiviral state in both senescent healthy and IPF fibroblasts. Consistent with the network and transcription factor analyses, siRNA-mediated depletion of IRF3 or STAT1 significantly reduced IFN-{beta} secretion in senescent healthy fibroblasts, whereas IPF fibroblasts showed only milder effects, indicating a disease-specific dependence on these pathways for antiviral control. Together, these findings show that the combination of cellular senescence and fibrotic fibroblast identity creates a dysfunctional antiviral state that may help explain the high susceptibility of IPF patients to virus-associated acute exacerbations and disease worsening.
- organism: human
- assay: bulk RNA-seq
- research focus: cell type annotation
- research focus: differential expression
- research focus: gene regulatory network inference
- approach: statistical model
- approach: experimental assay
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Loss of ANT1 Increases Fibrosis and Epithelial Cell Senescence in Idiopathic Pulmonary Fibrosis
J. C. Boatz, J. Sui, … C. Kliment·bioRxiv·Sep 9, 2022
- Effects of anti-fibrotic standard of care drugs on senescent human lung fibroblasts
S. Garcia, M. Hohmann, … C. M. Hogaboam·bioRxiv·May 6, 2022
- Uncovering senescent fibroblast heterogeneity connects DNA damage response to idiopathic pulmonary fibrosis
Jun‐Wei B. Hughes, Akshay Pujari, … Judith Campisi·npj AgingPeer-reviewed·Jun 18, 2026
- IGFBP2 protects against pulmonary fibrosis through inhibiting P21-mediated senescence
Chiahsuan Chin, John Lee, … Angara Sureshbabu·bioRxiv·Jan 21, 2021
- Substrate stiffness engineered to replicate disease conditions influence senescence and fibrotic responses in primary lung fibroblasts
K. E. C. Blokland, M. Nizamoglu, … J. K. Burgess·bioRxiv·Sep 27, 2022
- Senescence of alveolar stem cells drives progressive pulmonary fibrosis
C. Yao, X. Guan, … B. R. Stripp·bioRxiv·Nov 18, 2019